# The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2021

S.R. 2021/221 · made 28 July 2021

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (S.R. 2002 No. 1) (“the Regulations”).

Made under: Misuse of Drugs Act 1971 (Section 7, Section 10, Section 31, Section 38)

PDFs: Printed copy https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2021/pdf/nisr_20210221_en.pdf; NI Explanatory Memorandum https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2021/pdf/nisrem_20210221_en_001.pdf; NI Explanatory Memorandum https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2021/pdf/nisrem_20210221_en.pdf

## Introductory text

Dangerous Drugs
Made 28th July 2021
Coming into operation 18th August 2021
The Department of Health makes the following Regulations in exercise of the powers conferred by sections 7, 10 and 31 of the Misuse of Drugs Act 1971 as adapted by sections 7(9), 31(4) and 38 of that Act and now vested in it and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

## 1 Citation, commencement and interpretation

(1) These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2021 and shall come into operation on 18th August 2021.
(2) The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.

## 2 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002

(1) The following amendments are made to Schedule 1 to the Misuse of Drugs Regulations (Northern Ireland) 2002 (which specifies controlled drugs that are subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27 of those Regulations).
(2) In paragraph 1(a)—
(a) after “Etryptamine” insert “Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(b) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H -[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;
(c) after “Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”.

## Signature

Sealed with the Official Seal of the Department of Health on 28th July 2021
(L.S.)
Cathy Harrison
A senior officer of the Department of Health

## Explanatory note

(This note is not part of the Regulations)
These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (S.R. 2002 No. 1) (“the Regulations”).
Regulation 2 adds three benzodiazepines, being the compounds known as flualprazolam, flunitrazolam and norfludiazepam, to Schedule 1 to the Regulations. The Schedule of the Regulations in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls, requiring a licence from the Department of Health in order to access such drugs.

---
Source: https://www.legislation.gov.uk/nisr/2021/221 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-amendment-regulations-northern-ireland-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.